Helen of Troy Ltd (HELE) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock is facing significant financial challenges, negative technical indicators, weak trading sentiment, and a lack of positive catalysts. It is better to avoid this stock at the moment.
The technical indicators for HELE are bearish. The MACD histogram is negative and expanding, the RSI is neutral at 23.153, and the moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading near its key support level of 14.968, with resistance at 16.832. The stock trend analysis predicts further declines in the short and medium term.

NULL identified. The company's recent product launches (e.g., Revlon VersaStyler™) are not directly tied to Helen of Troy's core operations and do not provide a clear positive impact.
Faruqi & Faruqi LLP is investigating potential claims against Helen of Troy following a significant decline in financial performance.
The company reported a GAAP diluted loss per share of $13.44 and a 25% stock price drop after its Q2 fiscal 2026 earnings report.
Analysts have downgraded the stock and lowered price targets, citing weak guidance and profitability challenges.
Helen of Troy's Q3 2026 financial performance is weak. Revenue dropped by 3.37% YoY to $512.83 million, Net Income plummeted by 269.41% YoY to -$84.06 million, and EPS fell by 268.20% YoY to -$3.65. Gross Margin also declined by 4.07% YoY to 46.87%. These metrics indicate significant financial struggles.
Analysts have a neutral to negative outlook on HELE. UBS and Canaccord lowered their price targets to $22 and $23, respectively, citing weak guidance and profitability challenges. Goldman Sachs downgraded the stock to 'Sell,' citing downside risks to consensus estimates despite operational execution and improving fundamentals in some areas.